1. Vascular Endothelial Growth Factor Promotes Proliferation of Epithelial Cell Adhesion Molecule–Positive Cells in Nonalcoholic Steatohepatitis
- Author
-
Naveen Arora, Savneet Kaur, Chaggan Bihari, Hamda Siddiqui, and Preety Rawal
- Subjects
Hepatology ,medicine.diagnostic_test ,business.industry ,Angiogenesis ,Epithelial cell adhesion molecule ,medicine.disease ,digestive system diseases ,Umbilical vein ,Flow cytometry ,Vascular endothelial growth factor ,03 medical and health sciences ,chemistry.chemical_compound ,0302 clinical medicine ,medicine.anatomical_structure ,chemistry ,Fibrosis ,030220 oncology & carcinogenesis ,Hepatocyte ,Cancer research ,medicine ,Original Article ,030211 gastroenterology & hepatology ,Progenitor cell ,business - Abstract
AIM: An impaired hepatocyte proliferation during severe liver injury causes the proliferation of hepatic progenitor cells (HPCs), also called as the ductular reaction (DR). In the present study, we studied the role of key angiogenic factors in HPC-mediated DR in nonalcoholic steatohepatitis (NASH). METHODS: Liver biopsies from patients with NASH (n = 14) were included in the study. Patients with NASH were divided in two groups, early and late fibrosis (based on fibrosis staging). Biopsies were used to analyze the gene expression by quantitative real-time polymerase chain reaction and immunohistochemical (IHC) staining for two markers of DR, viz, CK19 and epithelial cell adhesion molecule (EpCAM). Cocultures were performed between steatotic human umbilical vein endothelial cells (HUVECs) and LX2 and Huh7 cells. Enzyme-linked immunosorbent assays were performed to measure levels of vascular endothelial growth factor (VEGF) in coculture studies. Next, Huh7 cells were treated with VEGF, and proliferation was investigated by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium (MTT) assays. The number of EpCAM-positive cells was analyzed by flow cytometry. RESULTS: Of all the angiogenic factors, the gene expression of VEGF and angiopoietin 2 (Ang2) was significantly different between patients with NASH in the early and late fibrosis groups (P
- Published
- 2020
- Full Text
- View/download PDF